Wilmington Healthcare
Looking Forward
NHS England and NHS Improvement have released their guidance setting out the expectations for commissioners and providers in updating their operational plans for 2018/19.

But what does this updated guidance mean for pharma and medtech companies?
  •   What impact will additional funding provided have on the NHS?
  •   Which medicines will see a reduction in prescribing?
  •   What’s the future for STPs?
  •   What is an Integrated Care Systems and what are they responsible for?
  •   How will medicines optimisation affect primary care homes?

Complete the below form to download the full NHS Planning Guidance 2018/19 overview.